Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$87.2 - $114.05 $71,416 - $93,406
-819 Reduced 26.65%
2,254 $242,000
Q1 2022

May 13, 2022

SELL
$94.19 - $124.49 $69,323 - $91,624
-736 Reduced 19.32%
3,073 $341,000
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $162,615 - $189,135
-1,360 Reduced 26.31%
3,809 $488,000
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $10,917 - $14,235
-100 Reduced 1.9%
5,169 $687,000
Q2 2021

Aug 10, 2021

SELL
$100.34 - $115.69 $72,345 - $83,412
-721 Reduced 12.04%
5,269 $570,000
Q1 2021

May 10, 2021

BUY
$101.51 - $125.27 $26,595 - $32,820
262 Added 4.57%
5,990 $630,000
Q4 2020

Feb 11, 2021

BUY
$85.88 - $105.36 $31,174 - $38,245
363 Added 6.77%
5,728 $597,000
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $18,694 - $23,772
257 Added 5.03%
5,365 $459,000
Q2 2020

Aug 17, 2020

BUY
$48.02 - $79.04 $30,924 - $50,901
644 Added 14.43%
5,108 $375,000
Q1 2020

May 11, 2020

BUY
$36.95 - $62.95 $29,079 - $49,541
787 Added 21.4%
4,464 $232,000
Q4 2019

Feb 04, 2020

SELL
$47.06 - $56.64 $28,236 - $33,984
-600 Reduced 14.03%
3,677 $225,000
Q3 2019

Nov 07, 2019

BUY
$47.45 - $58.05 $11,862 - $14,512
250 Added 6.21%
4,277 $208,000
Q2 2019

Aug 12, 2019

BUY
$39.26 - $54.21 $158,100 - $218,303
4,027 New
4,027 $228,000
Q2 2018

Aug 14, 2018

SELL
$38.72 - $42.52 $669,042 - $734,703
-17,279 Closed
0 $0
Q1 2018

May 09, 2018

SELL
$39.4 - $47.39 $11,820 - $14,217
-300 Reduced 1.71%
17,279 $708,000
Q3 2017

Oct 11, 2017

BUY
$33.75 - $41.67 $593,291 - $732,516
17,579
17,579 $703,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Cigna Investments Inc Portfolio

Follow Cigna Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cigna Investments Inc , based on Form 13F filings with the SEC.

News

Stay updated on Cigna Investments Inc with notifications on news.